These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 15012986

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Thyroid hormone export from cells: contribution of P-glycoprotein.
    Mitchell AM, Tom M, Mortimer RH.
    J Endocrinol; 2005 Apr; 185(1):93-8. PubMed ID: 15817830
    [Abstract] [Full Text] [Related]

  • 3. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
    Regev R, Katzir H, Yeheskely-Hayon D, Eytan GD.
    FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
    [Abstract] [Full Text] [Related]

  • 4. Overcoming multidrug-resistance in cancer: statins offer a logical candidate.
    Mehta NG, Mehta M.
    Med Hypotheses; 2010 Feb; 74(2):237-9. PubMed ID: 19879695
    [Abstract] [Full Text] [Related]

  • 5. Altered spectrum of multidrug resistance associated with a single point mutation in the Escherichia coli RND-type MDR efflux pump YhiV (MdtF).
    Bohnert JA, Schuster S, Fähnrich E, Trittler R, Kern WV.
    J Antimicrob Chemother; 2007 Jun; 59(6):1216-22. PubMed ID: 17062614
    [Abstract] [Full Text] [Related]

  • 6. MdfA, an interesting model protein for studying multidrug transport.
    Bibi E, Adler J, Lewinson O, Edgar R.
    J Mol Microbiol Biotechnol; 2001 Apr; 3(2):171-7. PubMed ID: 11321570
    [Abstract] [Full Text] [Related]

  • 7. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS, Choi WC, Rhee YH, Lee HJ, Lee EO, Ahn KS, Bae HS, Ahn KS, Kang JM, Choi SU, Kim MO, Lu J, Kim SH.
    Life Sci; 2008 Nov 21; 83(21-22):700-8. PubMed ID: 18845169
    [Abstract] [Full Text] [Related]

  • 8. Bacterial efflux pump inhibitors from natural sources.
    Stavri M, Piddock LJ, Gibbons S.
    J Antimicrob Chemother; 2007 Jun 21; 59(6):1247-60. PubMed ID: 17145734
    [Abstract] [Full Text] [Related]

  • 9. In search of natural substrates and inhibitors of MDR pumps.
    Lewis K.
    J Mol Microbiol Biotechnol; 2001 Apr 21; 3(2):247-54. PubMed ID: 11321580
    [Abstract] [Full Text] [Related]

  • 10. Mechanism of multidrug resistance in relation to passive membrane permeation.
    Eytan GD.
    Biomed Pharmacother; 2005 Apr 21; 59(3):90-7. PubMed ID: 15795101
    [Abstract] [Full Text] [Related]

  • 11. [Active membrane transport and bacterial multiple antibiotic resistance].
    Viktorov DV, Piven' NN.
    Mol Gen Mikrobiol Virusol; 2001 Apr 21; (3):3-8. PubMed ID: 11534397
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Single-cell-kinetics approach to compare multidrug resistance-associated membrane transport in subpopulations of cells.
    Koshkin V, Krylov SN.
    Anal Chem; 2011 Aug 15; 83(16):6132-4. PubMed ID: 21770449
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The tyrosine kinase inhibitors imatinib and AG957 reverse multidrug resistance in a chronic myelogenous leukemia cell line.
    Yeheskely-Hayon D, Regev R, Eytan GD, Dann EJ.
    Leuk Res; 2005 Jul 15; 29(7):793-802. PubMed ID: 15927675
    [Abstract] [Full Text] [Related]

  • 16. Using molecular symmetry to form new drugs: hydroxymethyl-substituted 3,9-diazatetraasteranes as the first class of symmetric MDR modulators.
    Hilgeroth A, Molnár J, De Clercq E.
    Angew Chem Int Ed Engl; 2002 Oct 04; 41(19):3623-5. 3516. PubMed ID: 12370910
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A review of selected anti-tumour therapeutic agents and reasons for multidrug resistance occurrence.
    Sawicka M, Kalinowska M, Skierski J, Lewandowski W.
    J Pharm Pharmacol; 2004 Sep 04; 56(9):1067-81. PubMed ID: 15324475
    [Abstract] [Full Text] [Related]

  • 19. Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges.
    Zhang D, Fan D.
    Expert Rev Anticancer Ther; 2007 Oct 04; 7(10):1369-78. PubMed ID: 17944563
    [Abstract] [Full Text] [Related]

  • 20. Fluoxetine inhibits multidrug resistance extrusion pumps and enhances responses to chemotherapy in syngeneic and in human xenograft mouse tumor models.
    Peer D, Dekel Y, Melikhov D, Margalit R.
    Cancer Res; 2004 Oct 15; 64(20):7562-9. PubMed ID: 15492283
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.